» Articles » PMID: 12404176

Seroconversion Against Lutzomyia Longipalpis Saliva Concurrent with the Development of Anti-Leishmania Chagasi Delayed-type Hypersensitivity

Overview
Journal J Infect Dis
Date 2002 Oct 31
PMID 12404176
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Antibody responses to salivary gland sonicate (SGS) from Lutzomyia longipalpis were investigated using serum samples from individuals living in an area where visceral leishmaniasis is endemic. Individuals were classified into 2 groups, according to the alteration of their responses to Leishmania chagasi antigen over the course of 6 months. Group 1 included children who experienced anti-L. chagasi seroconversion from negative to positive; group 2 included children who experienced delayed-type hypersensitivity (DTH) response to L. chagasi antigen conversion from negative to positive. Individuals who experienced seroconversion against L. chagasi antigens did not have increased anti-saliva antibody response, whereas those who developed a positive anti-L. chagasi DTH response had increased immunoglobulin (Ig) G, IgG1 and IgE anti-SGS antibody levels. Despite wide variation, serum samples from individuals in group 2 recognized more bands in SGS than did those from individuals in group 1. This simultaneous appearance of anti-saliva humoral response and anti-L. chagasi cell-mediated immunity supports the hypothesis that induction of immune response against SGS can facilitate induction of a protective response against leishmaniasis.

Citing Articles

Efficacy of LaAg Vaccine Associated with Saponin Against Infection.

de Mello M, Machado P, Gomes P, Oliveira-Silva G, Carneiro M, Ramos T Vaccines (Basel). 2025; 13(2).

PMID: 40006676 PMC: 11861163. DOI: 10.3390/vaccines13020129.


LmCen based vaccine is protective against canine visceral leishmaniasis following three natural exposures in Tunisia.

Boussoffara T, Labidi I, Trimeche M, Chelbi I, Dachraoui K, Msallem N NPJ Vaccines. 2025; 10(1):31.

PMID: 39952958 PMC: 11828870. DOI: 10.1038/s41541-025-01070-8.


Some Good and Some Bad: Sand Fly Salivary Proteins in the Control of Leishmaniasis and in Autoimmunity.

Aoki V, Abdeladhim M, Li N, Cecilio P, Prisayanh P, Diaz L Front Cell Infect Microbiol. 2022; 12:839932.

PMID: 35281450 PMC: 8913536. DOI: 10.3389/fcimb.2022.839932.


Human immune response to salivary gland antigens in a leishmaniasis-endemic focus in Iran.

Veysi A, Mahmoudi A, Yaghoobi-Ershadi M, Jeddi-Tehrani M, Rassi Y, Zahraei-Ramazani A Pathog Glob Health. 2020; 114(6):323-332.

PMID: 32643589 PMC: 7480592. DOI: 10.1080/20477724.2020.1789399.


Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as a Leishmania Vaccine Candidate.

Chen W, Nyon M, Poongavanam M, Liu Z, Biter A, Kundu R J Pharm Sci. 2020; 109(5):1673-1680.

PMID: 32070701 PMC: 7125844. DOI: 10.1016/j.xphs.2020.02.004.